Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
43.33
-1.22 (-2.74%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Qiagen Revenue
In the year 2025, Qiagen had annual revenue of $2.09B with 5.65% growth. Qiagen had revenue of $540.42M in the quarter ending December 31, 2025, with 3.69% growth.
Revenue (ttm)
$2.09B
Revenue Growth
+5.65%
P/S Ratio
4.27
Revenue / Employee
$350,260
Employees
5,967
Market Cap
8.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.09B | 111.79M | 5.65% |
| Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Charles River Laboratories International | 4.02B |
| Exact Sciences | 3.25B |
| Revvity | 2.86B |
| Medpace Holdings | 2.53B |
QGEN News
- 11 hours ago - Qiagen N.V. (QGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript - Seeking Alpha
- 7 days ago - Qiagen N.V. (QGEN) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 18 days ago - Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery - Business Wire
- 4 weeks ago - Qiagen N.V. (QGEN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars - Business Wire
- 4 weeks ago - QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026 - Business Wire
- 5 weeks ago - Qiagen: Takeover Optionality With A High-Quality Consumables Platform - Seeking Alpha
- 6 weeks ago - QIAGEN Appoints Mark Stevenson to Supervisory Board - Business Wire